Related Experiment Video
Updated: Aug 20, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Arsenic trioxide inhibits proliferation in K562 cells by changing cell cycle and survivin expression
Xiaofei Wu1, Zhichao Chen, Zhongping Liu
1Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Abstract:
To study the mechanisms involved in the inhibition of chronic myeloid leukemic cells (K562) proliferation induced by arsenic trioxide (As2O3) and to explore the potential role of Survivin, an inhibitor of apoptosis protein, in the regulation of As2O3 induced cell apoptosis, K562 cells were cultured with As2O3 of different concentrations. Cells were collected for proliferation analysis by MTT assay. Cell cycle distribution and cell apoptosis were analyzed by flow cytometry. Expression of Survivin protein and mRNA were detected by flow cytometry and RT-PCR, respectively. Our results showed that As2O3(2-10 micromol/L) inhibited K562 cells growth effectively, but it did not induce cells apoptosis significantly. The percentage of K562 cells at G2/M phase increased in proportion to As2O3 concentrations, and the expression of Survivin mRNA and content of Survivin protein was up-regulated accordingly. It is concluded that As2O3 inhibited K562 cells growth by inducing cell cycle arrest mainly at G2/M phase. Over-expression of Survivin gene and protein might be one of the possible mechanisms contributing to K562 cells' resistance to As2O3-induced apoptosis.
Insights
Arsenic trioxide inhibits chronic myeloid leukemia (K562) cell growth by arresting the cell cycle at the G2/M phase. Increased Survivin expression may contribute to K562 cells resistance to arsenic trioxide-induced apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm.
- Arsenic trioxide (As2O3) is a chemotherapeutic agent with demonstrated efficacy in certain leukemias.
- Survivin is an inhibitor of apoptosis protein (IAP) implicated in cancer cell survival and drug resistance.
Purpose of the Study:
- To elucidate the mechanisms by which As2O3 inhibits K562 cell proliferation.
- To investigate the role of Survivin in As2O3-induced apoptosis in K562 cells.
Main Methods:
- K562 cells were treated with varying concentrations of As2O3.
- Cell proliferation was assessed using MTT assay.
- Cell cycle distribution and apoptosis were analyzed by flow cytometry.
- Survivin protein and mRNA expression were quantified via flow cytometry and RT-PCR, respectively.
Main Results:
- As2O3 (2-10 micromol/L) significantly inhibited K562 cell growth without inducing substantial apoptosis.
- A dose-dependent increase in G2/M phase cell cycle arrest was observed with As2O3 treatment.
- Survivin mRNA and protein expression were upregulated in response to As2O3 exposure.
Conclusions:
- As2O3 inhibits K562 cell proliferation primarily through G2/M phase cell cycle arrest.
- Upregulation of Survivin may confer resistance to As2O3-induced apoptosis in K562 cells, suggesting a potential therapeutic target.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

